Literature DB >> 10586092

Antibody repertoires of four- and five-feature translocus mice carrying human immunoglobulin heavy chain and kappa and lambda light chain yeast artificial chromosomes.

I C Nicholson1, X Zou, A V Popov, G P Cook, E M Corps, S Humphries, C Ayling, B Goyenechea, J Xian, M J Taussig, M S Neuberger, M Brüggemann.   

Abstract

We have produced mice that carry the human Ig heavy (IgH) and both kappa and lambda light chain transloci in a background in which the endogenous IgH and kappa loci have been inactivated. The B lymphocyte population in these translocus mice is restored to about one-third of normal levels, with preferential (3:1) expression of human lambda over human kappa. Human IgM is found in the serum at levels between 50 and 400 microg/ml and is elevated following immunization. This primary human Ab repertoire is sufficient to yield diverse Ag-specific responses as judged by analysis of mAbs. The use of DH and J segments is similar to that seen in human B cells, with an analogous pattern of N nucleotide insertion. Maturation of the response is accompanied by somatic hypermutation, which is particularly effective in the light chain transloci. These mice therefore allow the production of Ag-specific repertoires of both IgM,kappa and IgM,lambda Abs and should prove useful for the production of human mAbs for clinical use.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10586092

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Heavy-chain only antibodies derived from dromedary are secreted and displayed by mouse B cells.

Authors:  Viet Khong Nguyen; Xiangang Zou; Marc Lauwereys; Lea Brys; Marianne Brüggemann; Serge Muyldermans
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

Review 2.  Recombinant antibodies for the diagnosis and treatment of cancer.

Authors:  Jürgen Krauss
Journal:  Mol Biotechnol       Date:  2003-09       Impact factor: 2.695

3.  Specific in vivo deletion of B-cell subpopulations expressing human immunoglobulins by the B-cell superantigen protein L.

Authors:  Muriel Viau; Nancy S Longo; Peter E Lipsky; Lars Björck; Moncef Zouali
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

Review 4.  Mining human antibody repertoires.

Authors:  Roger R Beerli; Christoph Rader
Journal:  MAbs       Date:  2010-07-01       Impact factor: 5.857

5.  Subversion of B lymphocyte tolerance by hydralazine, a potential mechanism for drug-induced lupus.

Authors:  Lynda Mazari; Meryem Ouarzane; Moncef Zouali
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-02       Impact factor: 11.205

6.  Camelid Ig V genes reveal significant human homology not seen in therapeutic target genes, providing for a powerful therapeutic antibody platform.

Authors:  Alex Klarenbeek; Khalil El Mazouari; Aline Desmyter; Christophe Blanchetot; Anna Hultberg; Natalie de Jonge; Rob C Roovers; Christian Cambillau; Sylvia Spinelli; Jurgen Del-Favero; Theo Verrips; Hans J de Haard; Ikbel Achour
Journal:  MAbs       Date:  2015       Impact factor: 5.857

Review 7.  Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.

Authors:  Saul Tzipori; Abhineet Sheoran; Donna Akiyoshi; Arthur Donohue-Rolfe; Howard Trachtman
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Immunogenicity of different stressed IgG monoclonal antibody formulations in immune tolerant transgenic mice.

Authors:  Vasco Filipe; Wim Jiskoot; Abdul Hafid Basmeleh; Andhyk Halim; Huub Schellekens; Vera Brinks
Journal:  MAbs       Date:  2012-09-05       Impact factor: 5.857

9.  Production and characterization of high-affinity human monoclonal antibodies to human immunodeficiency virus type 1 envelope glycoproteins in a mouse model expressing human immunoglobulins.

Authors:  Neil C Sheppard; Sarah L Davies; Simon A Jeffs; Sueli M Vieira; Quentin J Sattentau
Journal:  Clin Vaccine Immunol       Date:  2006-12-13

10.  High-affinity IgG antibodies develop naturally in Ig-knockout rats carrying germline human IgH/Igκ/Igλ loci bearing the rat CH region.

Authors:  Michael J Osborn; Biao Ma; Suzanne Avis; Ashleigh Binnie; Jeanette Dilley; Xi Yang; Kevin Lindquist; Séverine Ménoret; Anne-Laure Iscache; Laure-Hélène Ouisse; Arvind Rajpal; Ignacio Anegon; Michael S Neuberger; Roland Buelow; Marianne Brüggemann
Journal:  J Immunol       Date:  2013-01-09       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.